Pyrazolylamine Derivatives Reveal the Conformational Switching between Type i and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK)
Most anaplastic lymphoma kinase (ALK) inhibitors adopt a type I binding mode, but only limited type II ALK structural studies are available. Herein, we present the structure of ALK in complex with N1-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino
Get Best Price for1395050-47-1N-[3-(4-{[(5-(tert-butyl)-1,2-oxazol-3-yl)carbamoyl]amino}phenyl)-1H-pyrazol-5-yl]-4-[3-(pyrrolidin-1-yl)propoxy]benzamide